Vetoquinol
VETO.PAVetoquinol is an independent, family-founded animal health company with a mission to improve animal health and well-being through innovative pharmaceutical solutions. The company has built a strong international presence, generating over €500 million in annual revenue through a direct commercial footprint in key markets and a network of distributors. Its strategy focuses on therapeutic innovation, geographic expansion, and strategic acquisitions to strengthen its position in the high-growth animal health market, which is driven by trends in pet humanization, food safety, and livestock productivity.
VETO.PA · Stock Price
Historical price data
AI Company Overview
Vetoquinol is an independent, family-founded animal health company with a mission to improve animal health and well-being through innovative pharmaceutical solutions. The company has built a strong international presence, generating over €500 million in annual revenue through a direct commercial footprint in key markets and a network of distributors. Its strategy focuses on therapeutic innovation, geographic expansion, and strategic acquisitions to strengthen its position in the high-growth animal health market, which is driven by trends in pet humanization, food safety, and livestock productivity.
Technology Platform
Applied veterinary pharmaceutical R&D focused on novel formulations, delivery systems, and lifecycle management of pharmaceutical products for companion animals and livestock.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Vetoquinol competes against giants like Zoetis, Merck, and Boehringer Ingelheim. Its differentiation lies in its agility as an independent, mid-sized company, deep veterinary relationships, and focused innovation in specific therapeutic niches, allowing it to avoid direct, costly battles in the largest market segments.